These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3107241)

  • 1. Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin).
    Dinarello CA
    Year Immunol; 1986; 2():68-89. PubMed ID: 3107241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human interleukin 1 alpha: purification and biological characterization.
    Gubler U; Chua AO; Stern AS; Hellmann CP; Vitek MP; DeChiara TM; Benjamin WR; Collier KJ; Dukovich M; Familletti PC
    J Immunol; 1986 Apr; 136(7):2492-7. PubMed ID: 3485152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.
    Lachman LB; Dinarello CA; Llansa ND; Fidler IJ
    J Immunol; 1986 Apr; 136(8):3098-102. PubMed ID: 3485680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
    Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.
    Pober JS; Bevilacqua MP; Mendrick DL; Lapierre LA; Fiers W; Gimbrone MA
    J Immunol; 1986 Mar; 136(5):1680-7. PubMed ID: 3485132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species.
    Pober JS; Lapierre LA; Stolpen AH; Brock TA; Springer TA; Fiers W; Bevilacqua MP; Mendrick DL; Gimbrone MA
    J Immunol; 1987 May; 138(10):3319-24. PubMed ID: 3494766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of glycosylated human interleukin-1 alpha, neoglyco IL-1 alpha, coupled with D-mannose dimer: synthesis and biological activities in vitro.
    Takei Y; Wada K; Chiba T; Hayashi H; Ishihara H; Onozaki K
    Lymphokine Cytokine Res; 1994 Aug; 13(4):265-70. PubMed ID: 7999926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the biological properties of purified and recombinant human interleukin-1.
    Dinarello CA
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):57-61. PubMed ID: 3487013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1.
    Sipe JD; Vogel SN; Douches S; Neta R
    Lymphokine Res; 1987; 6(2):93-101. PubMed ID: 3495710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line.
    Lachman LB; Brown DC; Dinarello CA
    J Immunol; 1987 May; 138(9):2913-6. PubMed ID: 3494774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1: multiple biological properties and mechanisms of action.
    Dinarello CA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():900-4. PubMed ID: 2445184
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological activity of human epidermal interleukin-1beta: comparison with recombinant human interleukin-1beta.
    Lundqvist EN; Companjen AR; Prens EP; Egelrud T
    Eur Cytokine Netw; 1998 Mar; 9(1):41-6. PubMed ID: 9613676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Le J; Vilcek J
    Lab Invest; 1987 Mar; 56(3):234-48. PubMed ID: 3029503
    [No Abstract]   [Full Text] [Related]  

  • 15. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
    Beresini MH; Lempert MJ; Epstein LB
    J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.
    Denis F; Archambault D
    Can J Vet Res; 2001 Oct; 65(4):233-40. PubMed ID: 11768130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The acute phase reaction and its mediators. II: Alpha tumor necrosis factor and interleukin 6].
    Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1990 Jan; 28(1):14-21. PubMed ID: 2107643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological properties of interleukin-1.
    Dinarello CA
    Eur Cytokine Netw; 1994; 5(6):517-31. PubMed ID: 7727685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC; Harlan JM; Adamson JW
    J Immunol; 1987 Jun; 138(12):4298-302. PubMed ID: 3495589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin 1 (IL 1)].
    Nausch M; Friemel H
    Allerg Immunol (Leipz); 1989; 35(2):101-22. PubMed ID: 2528272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.